Recercat. Dipósit de la Recerca de Catalunya
Publication
Artículo científico (JournalArticle)
DNA methylation and gene expression signatures for common childhood infections
Background: Early life exposure to common pathogens and a high pathogen burden during childhood can have long-term effects on immune development and overall health. These infections can trigger molecular changes, including alterations in gene expression and DNA methylation (DNAm), which regulate immune and metabolic pathways. Our aim was to identify biological processes underlying differential patterns of DNAm and gene expression in whole blood by infection status in European children. Results: In the Rhea (Greece) and INMA (Spain) cohorts, serum/plasma samples collected at mean ages of 4 and 8 years were analyzed by multiplex serology to measure IgG against 14 antigens from 9 pathogens, and blood collected at a mean age of 8 years was used for DNAm and gene expression profiling. Epigenome- and transcriptome-wide analyses were conducted to assess association with childhood infections. A total of 290 unique CpGs were significantly associated with pathogen outcomes: 265 with seropositivity, 111 with first exposure timing, and one with viral burden. Cytomegalovirus (CMV) exposure accounted for the largest number of both epigenetic (n = 325) and transcriptomic (n = 8) associations. A total of 89 CMV-related CpGs had been described before in adults, and among novel ones, 54 showed consistent effects in adults. CMV-related CpGs were enriched for SUZ12 targets linked to morphogenesis, oxidative stress, and cognition. A previously developed CMV episcore in adults predicted serologically assessed CMV infection at 4 and 8 years of age, with area under the curve values ranging from 0.74 to 0.78 (95% CI 0.68-0.83). Conclusions: We identified novel DNAm and gene expression signatures of common childhood infections, particularly CMV, implicating immune and morphogenesis pathways. A subset of CMV-related DNAm signals showed consistent associations with those reported previously in adults, suggesting similar molecular effects across ages., This work was funded by La Marato de TV3 2017 [Project number 201819, Reg. 78 / 437, Title: “Infection acquisition in early life and health outcomes in childhood”], European Community’s Horizon 2020 research and innovation programme [874583] - Advancing Tools for Human Early Lifecourse Exposome research and Translation (ATHLETE project), the European Community’s Seventh Framework Programme [FP7/2007–2013] under grant agreement No 308333 – the Human Early Life Exposome (HELIX project) and CIBERESP. The INMA-SAB study was funded by grants from Instituto de Salud Carlos III [Red INMA G03/176; CB06/02/0041; PI041436; PI081151 incl. FEDER funds], CIBERESP, Generalitat de Catalunya-CIRIT [1999SGR 00241], Generalitat de Catalunya [AGAUR 2009 SGR 501], Fundació La Marató de TV3 [090430], EU Commission [261357]. The Rhea project was financially supported by European projects [EU FP6-2003-Food-3-NewGeneris, EU FP6. STREP Hiwate, EU FP7 NV.2007.1.2.2.2. Project No 211250 Escape, EU FP7-2008-ENV-1.2.1.4 Envirogenomarkers, EU FP7-HEALTH-2009- single stage CHICOS, EU FP7 ENV.2008.1.2.1.6. Proposal No 226285 ENRIECO, EU- FP7- HEALTH-2012 Proposal No 308333 HELIX] and the Greek Ministry of Health [Program of Prevention of obesity and neurodevelopmental disorders in preschool children, in Heraklion district, Crete, Greece: 2011–2014; “Rhea Plus”: Primary Prevention Program of Environmental Risk Factors for Reproductive Health, and Child Health: 2012-15]. ISGlobal acknowledges support from the Spanish Ministry of Science and Innovation [CEX2023-0001290-S] funded by MCIN/AEI/https://doi.org/10.13 039/501100011033, and support from the Generalitat de Catalunya through the CERCA Program. EHL was supported by a postdoctoral fellowship for the Severo Ochoa Program 2024–2028. Marianna Karachaliou has received funding from the European Union’s Horizon Europe research and innovation programme under the Marie Skłodowska-Curie Actions (MSCA) Postdoctoral Fellowships [101152509].
Project:
EC / H2020 874583
,
EC / FP7 308333
,
EC / FP7 261357
,
EC / FP7 211250
,
EC / FP7 226285
,
EC / HE 101152509